News for CARDINAL HEALTH (CAHD.BA)

**media[601191]**

We recently published a list of Jim Cramer is Bullish on These 10 Stocks. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks that Jim Cramer discusses. On Friday, Mad Money host, Jim Cramer, shared his perspective on how investors might approach the stock […]

Bank of America has increased its price target for McKesson (MCK) to $755, up from the previous target of $665, while maintaining a Buy rating on the stock. Thi

Bank of America analyst Allen Lutz has increased the price target for Cencora (COR) from $270 to $285, maintaining a Neutral rating on the stock. This adjustmen

Bank of America has raised its price target for Cardinal Health (CAH), boosting it from $150 to $155 while maintaining a Buy rating on the company's shares. Thi

**media[588854]**

Deep-pocketed investors have adopted a bearish approach towards McKesson MCK, and it's something market players shouldn't ignore. Our tracking of public options...

Here is how Cardinal Health (CAH) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cardinal Health (CAH) closed at $133.98 in the latest trading session, marking a +0.93% move from the prior day.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cardinal Health (CAH) concluded the recent trading session at $132.75, signifying a -0.35% move from its prior day's close.

Cardinal Health Inc (CAH), a leading distributor and manufacturer in the healthcare sector, has announced that it will release its third-quarter financial resul

PR NewswireDUBLIN, Ohio, March 25, 2025 DUBLIN, Ohio, March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial r

Cardinal Health's stock has surged 133% since May 2022, but its long-term chart reveals a history of prolonged correction. Read my analysis of CAH stock.

Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside potential.

/PRNewswire-PRWeb/ -- Women We Admire is pleased to announce The Top 50 Women Leaders of Georgia for 2025. As the eighth most populous state, Georgia is a...

In his Sunday column for Club subscribers, Jim Cramer examines whether large-cap tech stocks could once again act as safe-haven names.